Sector: Aesthetic Medicine
Main location: Switzerland (Geneva), Poland (Warsaw), US (Raleigh, North Carolina), Italy (Brindisi)
Investment date: October 2018
Investment cost: III
In October 2018, Abris invested in ITP S.A., a Polish company which sells its innovative aesthetic medicine products in more than 45 countries. Abris Capital Partners will provide the company with professional support and financing for further rapid international growth strategy, which assumes increasing presence on current markets and entry to new countries, such as USA and China.
ITP S.A. is a dynamically growing company operating on the aesthetic medicine, beauty, fitness and wellness market. It owns the Neauvia brand – a new generation of hyaluronic acid dermal fillers and a line of professional cosmeceuticals which are currently sold in more than 45 countries around the world.
In addition, the company specialises in selecting the best technologies and global brands on the aesthetic medicine, medical devices and wellness equipment market and then sells them successfully in Poland and worldwide.
ITP S.A.’s rapid development is also the result of its business strategy, based upon a unique and holistic approach to the client, the development of long-term relationships with partners and full support at all stages of cooperation.